Answers are grounded in this paper and cite their sources.
Five trends of China's pharmaceutical industry in 2022In recent years, China has started to encourage pharmaceutical enterprises to carry out research and development of innovative drugs.From 2018 to 2021, with the capital rapidly influx into the pharmaceutical industry, there were increasing numbers of financing events with growing amount year by year 1 .The rapid development of China's pharmaceutical industry in the past five years is also accompanied by bubbles.At the end of 2021, the industry started to face adjustment due to the impact of the pandemic and the economic environment.The number of investigational new drug applications (INDs), clinical trials, new drug applications (NDAs) and drug approvals of Chinese pharmaceutical companies throughout the year of 2022 has generally declined.The following will outline the pharmaceutical industry in 2022 from four aspects.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: